Soligenix Inc Earnings

The next earnings date for Soligenix Inc has not yet been scheduled.

Analyst Estimates of Soligenix Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Soligenix Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/08/2025Before Market$-1.06-58.21%
03/13/2025Before Market------
11/11/2024Before Market$-0.7828.44%
08/09/2024Before Market$-1.3125.99%
05/10/2024After Market$-0.185.26%
03/15/2024Before Market$-0.23-21.05%
11/13/2023Before Market$-0.1644.83%
08/21/2023After Market$-0.2255.10%
05/15/2023Before Market$-0.3671.20%
03/31/2023Before Market$-4.58-308.93%
11/10/2022After Market$-1.2011.11%
08/12/2022Before Market$-0.9025.00%
05/13/2022After Market$-1.50-42.86%
03/29/2022Before Market$-1.65-37.50%
11/12/2021Before Market$-1.3525.00%
08/13/2021Before Market$-0.7553.13%
05/17/2021Before Market$-0.9043.75%
03/30/2021Before Market$-2.40-100.00%
11/12/2020Before Market$-0.9047.06%
08/14/2020After Market$-1.5023.08%
05/15/2020After Market$-4.80-182.35%
03/30/2020Before Market$-2.10-5.53%
11/12/2019After Market$-2.10-7.69%
08/13/2019Before Market$-1.8012.20%
05/14/2019Before Market$-1.3533.17%
03/26/2019After Market$-2.70-20.00%
11/09/2018After Market$-1.65-16.20%
08/08/2018Before Market$-2.70-50.00%
05/11/2018Before Market$-0.27-8.00%
03/15/2018Before Market$-4.05-38.70%
11/06/2017After Market$-2.5529.17%
08/11/2017After Market$-6.15-28.13%
05/11/2017After Market$-4.8028.89%
03/27/2017Before Market$-0.4594.17%
11/10/2016After Market$-7.352.00%
08/11/2016After Market$-366.67%
05/12/2016Before Market$-90.00%
01/26/2016Before Market$-1-11.11%
11/12/2015Before Market$15225.00%
08/12/2015Before Market$-22.500.00%
05/14/2015After Market$-28.50-58.33%
03/24/2015Before Market$16.50283.33%
11/10/2014Before Market$-31.50-142.31%
08/11/2014---$-7.5044.44%
05/12/2014---$-25.50-142.86%
03/26/2014---$19.50273.33%
11/12/2013---$-51-300.00%
08/12/2013---$-15-42.86%
05/03/2013---$-1523.08%
02/26/2013---$-13.50-200.00%
11/09/2012---$-163.54---
08/10/2012---$-211.40---
05/11/2012---$-310.54---
03/27/2012---$-204.07---
11/14/2011---$2200.00%
08/12/2011---$-20.00%
05/13/2011---$-20.00%
03/29/2011---$-20.00%
11/12/2010---$-20.00%
08/13/2010---$-20.00%
05/17/2010---$-20.00%
11/14/2009---$-474.13---
08/14/2009---$-512.64---
05/15/2009---$-691.45---
03/26/2009---$-257.76---
11/14/2008---$-222.19---
08/15/2008---$-605.11---
05/16/2008---$-665.87---
11/13/2007---$-644.03---
08/15/2007---$-806.52---
05/16/2007---$-1,258.73---
03/12/2007---$-1,312.81---
11/14/2006---$-956.40---
08/14/2006---$-2,398.69---
05/15/2006---$-1,599.54---
03/30/2006---$-1,440---
11/14/2005---$-1,125.43---
08/15/2005---$-513.47---
05/16/2005---$-1,051.79---
03/14/2005---$-2,400---
11/15/2004---$-650.00%
08/13/2004---$-1,689.06---
05/16/2004---$-2,177.41---
03/31/2004---$-100.00%
11/19/2003---$-2,257.61---
08/13/2003---$-1,403.05---
03/31/2003---$-4,664.42---
09/30/2002---$-2,291.87---
06/30/2002---$-4,290.86---
03/31/2002---$-5,404.72---
09/30/2001---$-5,506.00---
06/30/2001---$-5,849.49---
03/31/2001---$-5,936.96---
09/30/2000---$-5,477.24---
06/30/2000---$-6,292.67---
03/31/2000---$-7,911.16---
09/30/1999---$-8,672.93---
06/30/1999---$-11,641.87---
03/31/1999---$-10,312.46---
09/30/1998---$-8,112.73---
06/30/1998---$-7,309.75---
03/31/1998---$-43,973.35---

More About Soligenix Inc

Website
https://www.soligenix.com
Country
USA
Full Time Employees
14

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in Phase 3 clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX945, an IDR technology that is in Phase 2a study to treat aphthous ulcers in Behçet's disease; and SGX302, an IDR technology, which is in Phase 2a study for the treatment of mild-to-moderate psoriasis. Its Public Health Solutions segment engages in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a, 1b, and 1c clinical trials; SGX943, a therapeutic candidate in preclinical studies for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; CiVax, a vaccine candidate for the prevention of COVID-19; and vaccine programs that target filoviruses, such as Marburg and Ebola. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in September 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.

“Soligenix Inc Earnings” Can Refer to the Soligenix Inc Earnings Date

Some people say “Soligenix Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Soligenix Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Soligenix Inc Stock on the Earnings Date

If you own Soligenix Inc stock (SNGX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Soligenix Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Soligenix Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Soligenix Inc Earnings

You can contact us any time if you would like to ask questions about Soligenix Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.